Sino Biopharmaceutica Valuation
| SBMFF Stock | USD 0.45 0.03 7.14% |
Sino Biopharmaceutica is overvalued. Sino Biopharmaceutical has a current Real Value of $0.36 per share. The regular price of the company is $0.45. Our model measures the value of Sino Biopharmaceutical from inspecting the company fundamentals such as Operating Margin of 0.16 %, shares outstanding of 18.81 B, and Return On Equity of 0.29 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Sino Biopharmaceutica's price fluctuation is abnormally volatile at this time. Calculation of the real value of Sino Biopharmaceutical is based on 3 months time horizon. Increasing Sino Biopharmaceutica's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Sino pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Sino Biopharmaceutical Limited. Since Sino Biopharmaceutica is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sino Pink Sheet. However, Sino Biopharmaceutica's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.45 | Real 0.36 | Hype 0.45 | Naive 0.46 |
The real value of Sino Pink Sheet, also known as its intrinsic value, is the underlying worth of Sino Biopharmaceutical Company, which is reflected in its stock price. It is based on Sino Biopharmaceutica's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Sino Biopharmaceutica's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Sino Biopharmaceutical Limited helps investors to forecast how Sino pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sino Biopharmaceutica more accurately as focusing exclusively on Sino Biopharmaceutica's fundamentals will not take into account other important factors: Sino Biopharmaceutica Total Value Analysis
Sino Biopharmaceutical Limited is at this time forecasted to have takeover price of 10.34 B with market capitalization of 10.91 B, debt of 5.21 B, and cash on hands of 15.67 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sino Biopharmaceutica fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
10.34 B | 10.91 B | 5.21 B | 15.67 B |
Sino Biopharmaceutica Investor Information
About 48.0% of the company outstanding shares are owned by corporate insiders. The book value of Sino Biopharmaceutica was at this time reported as 1.64. The company has Price/Earnings To Growth (PEG) ratio of 0.53. Sino Biopharmaceutical last dividend was issued on the 6th of September 2022. The entity had 3:2 split on the 4th of June 2018. Based on the key measurements obtained from Sino Biopharmaceutica's financial statements, Sino Biopharmaceutical Limited is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Sino Biopharmaceutica Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sino Biopharmaceutica has an asset utilization ratio of 44.37 percent. This implies that the Company is making $0.44 for each dollar of assets. An increasing asset utilization means that Sino Biopharmaceutical Limited is more efficient with each dollar of assets it utilizes for everyday operations.Sino Biopharmaceutica Ownership Allocation
Sino Biopharmaceutical shows a total of 18.81 Billion outstanding shares. Sino Biopharmaceutical maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sino Biopharmaceutica Profitability Analysis
The company reported the revenue of 26.86 B. Net Income was 14.61 B with profit before overhead, payroll, taxes, and interest of 21.53 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Sino Biopharmaceutica's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Sino Biopharmaceutica and how it compares across the competition.
About Sino Biopharmaceutica Valuation
The pink sheet valuation mechanism determines Sino Biopharmaceutica's current worth on a weekly basis. Our valuation model uses a comparative analysis of Sino Biopharmaceutica. We calculate exposure to Sino Biopharmaceutica's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sino Biopharmaceutica's related companies.Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the Peoples Republic of China. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong. Sino Biopharmaceutic is traded on OTC Exchange in the United States.
8 Steps to conduct Sino Biopharmaceutica's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Sino Biopharmaceutica's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Sino Biopharmaceutica's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Sino Biopharmaceutica's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Sino Biopharmaceutica's revenue streams: Identify Sino Biopharmaceutica's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Sino Biopharmaceutica's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Sino Biopharmaceutica's growth potential: Evaluate Sino Biopharmaceutica's management, business model, and growth potential.
- Determine Sino Biopharmaceutica's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Sino Biopharmaceutica's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Sino Biopharmaceutica Growth Indicators
Investing in growth stocks can be very risky. If the company such as Sino Biopharmaceutica does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 18.8 B | |
| Quarterly Earnings Growth Y O Y | -0.865 | |
| Forward Price Earnings | 20.6612 | |
| Retained Earnings | 27.2 B |
Complementary Tools for Sino Pink Sheet analysis
When running Sino Biopharmaceutica's price analysis, check to measure Sino Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sino Biopharmaceutica is operating at the current time. Most of Sino Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sino Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sino Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sino Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |